Hemangioendothelioma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 32: | Line 32: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Hemangioendothelioma staging|Staging]] | [[Hemangioendothelioma history and symptoms|History and Symptoms]] | [[Hemangioendothelioma physical examination|Physical Examination]] | [[Hemangioendothelioma laboratory tests| | [[Hemangioendothelioma staging|Staging]] | [[Hemangioendothelioma history and symptoms|History and Symptoms]] | [[Hemangioendothelioma physical examination|Physical Examination]] | [[Hemangioendothelioma laboratory tests|Laboratory Findings]] | [[Hemangioendothelioma x ray|X Ray]] | [[Hemangioendothelioma CT|CT]] | [[Hemangioendothelioma MRI|MRI]] | [[Hemangioendothelioma ultrasound|Ultrasound]] | [[Hemangioendothelioma other imaging findings|Other Imaging Findings]] | [[Hemangioendothelioma other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== |
Revision as of 18:38, 17 September 2012
For patient information, click here
Template:DiseaseDisorder infobox Template:Hemangioendothelioma Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Hemangioendothelioma from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies